Broadfin Capital Ups Position in Rigel Pharmaceuticals, Inc. (RIGL)

Kevin Kotler‘s Broadfin Capital increased its exposure to Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a filing with the SEC showed. Broadfin reported holding around 4.5 million shares of the company, up from some 3.6 million held at the end of September. The stake is passive by nature and amasses 5.1% of the company’s common stock.

Kevin Kotler

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is a clinical-stage drug development company. Earlier in October, the company provided updated regarding two of its pipeline products: R333 and Fostamatinib. The first drug, developed as a therapeutic for skin lesions for patients with discoid lupus erythematosus, did not meet the expectations in the Phase 2 clinical study, the company said in a statement. Rigel also conducted a meeting with FDA regarding the Phase 2 of fostamatinib, a drug for patients with immune thrombocytopenic purpura. The company plans to move on to Phase 3 studies during the next year.

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has also attracted some other hedge funds, which revealed ownership of shares in the latest round of 13F filings.William Leland Edwards Palo Alto Investors, owns, so far, the largest position, with 6.30 million shares, valued at $22.55 million; Millennium Management, managed by Israel Englander holds 2.89 million shares valued at $10.35 million. The fourth hedge fund with the largest stake in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is D E Shaw’s D. E. Shaw, which holds 1.09 million shares which is valued at $3.92 million.

Broadfin Capital invests primarily in the healthcare sector, with smaller interest in the services and other sectors.

In the last quarter, Broadfin Capital reported movement in some other companies, in addition to Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL):  Horizon Pharma Inc (NASDAQ:HZNP) and Alliqua Inc (OTCMKTS:ALQA). In Horizon Pharma Inc, the fund has moved to 3.9 million shares from its earlier 1.9 million shares, holding 5.9% of the company’s stock. In Alliqua Inc it holds 774,400 as shares, which is 7.8% of the common stock. Also, the fund has increased its position in Derma Sciences Inc (NASDAQ:DSCI) moving from 771,600 shares to 871,600 shares.

Disclosure: none

Recommended Reading:

Oz Management Reveals New Stake in American Airlines Group Inc (AAL)

Mario Gabelli, GAMCO Investors’ Latest Moves Involve Communications Systems, Inc. (JCS), Lawson Products, Inc. (LAWS) & More

Ken Griffin, Citadel Raise Exposure to Monolithic Power Systems, Inc. (MPWR), and AMC Entertainment Holdings Inc (AMC)

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Top 10 Highest Paying Jobs in the World

Most Expensive Day-Care in New York City

The 10 Cheapest Places to Retire Abroad

Top 10 Most Expensive Luxury Cars in the World – 2014

Killer Small Business Ideas

The 50 Best Personal Finance Blogs

Most Expensive Apartments in New York City

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!